Rankings
▼
Calendar
AXGN FY 2023 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
FY 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$159M
+14.7% YoY
Gross Profit
$122M
76.6% margin
Operating Income
-$21M
-13.5% margin
Net Income
-$22M
-13.7% margin
EPS (Diluted)
$-0.51
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$21M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$197M
Total Liabilities
$101M
Stockholders' Equity
$96M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$159M
$139M
+14.7%
Gross Profit
$122M
$109M
+12.0%
Operating Income
-$21M
-$30M
+27.8%
Net Income
-$22M
-$29M
+25.0%
← Q4 2022
All Quarters
Q1 2023 →